Open Beta
MetriLume

US marketsINGR

SEC-sourced researchBeta

INGR

Ingredion Inc

Company comparison ↗

Data passport

CIK
0001046257
Exchange
NYSE
Business activity
— · SIC 2040
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 8,160,000,000.0000 USD; December 2024: 7,430,000,000.0000 USD; December 2025: 7,219,000,000.0000 USD8.2B USD0 USD0December 2023December 2024December 2025
INGR · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20238,160,000,000.0000Feb 17, 2026
December 20247,430,000,000.0000Feb 17, 2026
December 20257,219,000,000.0000Feb 17, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20257,219,000,000.0000729,000,000.0000944,000,000.00007,897,000,000.00003,531,000,000.0000Feb 17, 2026
December 20247,430,000,000.0000647,000,000.00001,436,000,000.00007,444,000,000.00003,554,000,000.0000Feb 17, 2026
December 20238,160,000,000.0000643,000,000.00001,057,000,000.0000——Feb 17, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$7.22BDecember 2025Feb 17, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$7.43BDecember 2024Feb 17, 202610-K
Net incomeNetIncomeLoss$729MDecember 2025Feb 17, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$944MDecember 2025Feb 17, 202610-K
Total assetsAssets$7.9BDecember 2025Feb 17, 202610-K
Total liabilitiesLiabilities$3.53BDecember 2025Feb 17, 202610-K

New filings

Explore methodology ↗